Below we have assembled a brief guide to explain our investment process and how to get started. Whether your company receives investment from Ben Franklin or not, you will derive value from our thorough and transparent process.
NOTE: This is the typical investment process; however, each sector may have nuances that deviate from the outline below. To get oriented with what each sector specifically looks for at each step, please review the guidance material and application documents below for your sector.
Health & Digital Health
|IT Guidance Document
IT Application Document
IT Review Cycle Dates
|Health & Digital Health Guidance Document
Health & Digital Health Application Document
Health & Digital Health Review Cycle Dates
|Physical Sciences Guidance Document
Physical Sciences Application Document
Physical Sciences Cycle Dates
Before starting the formal application process, we would like to get to know you and your company so we can make some recommendations in regard to timing and investment expectations. In order to provide some context for our conversation, it is often helpful to submit an executive summary. To get the conversation started, contact information is provided below.
If after our initial conversation it is mutually decided the timing is right, we will e-mail you our application template. Please return the completed application and the $500.00 application fee to continue to the evaluation stage.
Guidance is provided by the Investment Group, should you need assistance.
After receiving your application and fee, we will invite you to pitch in front of our review committee. This meeting is attended by the Investment Director, outside industry professionals, and investors.
If the company passes these steps to our satisfaction we will advance your company to formal due diligence.
All review cycle dates are in the above guidance documents.
Depending on the sector, a follow-up presentation may be required to address issues found during due diligence. Again, please refer to the Guidance Documents for your sector’s specific requirement.
Omar Mencin, Director of Investments
Rick Genzer, Director of Investments
Jonathon Beschen, Manager, Technology Commercialization
Health & Digital Health
Jennifer Hartt, Director of Investments
John Prendergass, Associate Director
Sri Sriadibhatla, Senior Manager, Technology Commercialization
Mark deGrandpre, Director of Investments
Mark Trabbold, Director, Technology Commercialization